12:00 AM
 | 
Apr 25, 2011
 |  BC Week In Review  |  Company News  |  Sales & Marketing

J&J sales and marketing update

Johnson & Johnson's Ortho-McNeil-Janssen Pharmaceuticals Inc. unit recalled two lots, 0KG110 and 0LG222, of 100 mg Topamax topiramate tablets in the U.S. and Puerto Rico because of an uncharacteristic...

Read the full 135 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >